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similar enzyme would be operative in the breakdown of 2-hydroxyphytanoyl-CoA, one would expect formation of pristanal as intermediary metabolite next to formyl-CoA. Further NAD / dependent oxidation of pristanal to pristanic acid could occur by a similar Phytanic acid (3,7,11,15-tetramethylhexadecanoic mechanism as described for other fatty aldehydes [8] . acid) is first metabolised by a-oxidation, as b-oxidation
In this paper we show that pristanal is produced is blocked by the methyl group in the 3-position. The from 2-hydroxyphytanoyl-CoA and undergoes further product of a-oxidation is pristanic acid (2,6,10,14-tetra-NAD / dependent oxidation to pristanic acid. Our data methylpentadecanoic acid), which can be further melead us to conclude that the long-sought structure of the tabolised by peroxisomal b-oxidation. The elucidation phytanic acid a-oxidation pathway is finally resolved, of the mechanism and the subcellular localisation of the after more than 25 years of study. a-oxidation process have taken many years of debate in literature already. However, recent data have shed new light on the pathway of phytanic acid a-oxidation. It is MATERIALS AND METHODS now known that, after activation to phytanoyl-CoA, 2hydroxyphytanoyl-CoA is formed in a reaction cata-Materials. 2-Hydroxyphytanic acid, pristanic acid and [2-methyl- lysed by phytanoyl-CoA hydroxylase [1, 2, 3] . This dioxy-2 H 3 ]pristanic acid were synthesized as described before [9]. 2-Hydroxyphytanoyl-CoA was synthesised from 2-hydroxyphytanic acid genase type of enzyme requires Fe 2/ and ascorbate as using the mixed anhydride method [10] .
cofactors and a-ketoglutarate as cosubstrate, as was Pristanal ethoxime was synthesized in the Free University Hospital Amsterdam with a purity of ú99%. Dodecylaldehyde (purity ú96%) was obtained from Janssen Chimica (Belgium). mM EDTA at a final pH of 7.4. Protein concentrations were determined using an established method [11] .
The incubations contained the following components: 1 mg of total liver homogenate, 150 mM KCl, 50 mM Hepes-NaOH, 2 mM potassium phosphate, 10 mM defatted bovine serum albumin and 0.02 mM 2-hydroxyphytanoyl-CoA. The volume was 1 ml and the final pH was 7.4. To some of the incubations, 1 mM NAD / was added. 200 ml aliquots of the incubations were taken at the start of the reaction and after 10, 30, 60 and 120 minutes. For analysis of pristanal, to these aliquots, 100 ml ethoxylamine (0.1 g/ml) in water was added immediately and the pH was increased to ú10 by addition of Na 2 CO 3 . 0.6 nmol dodecylaldehyde was added as internal standard. Hereafter, fatty ethoxime esters were extracted with 2 ml of diethylether by shaking the samples during 1 hour. The ether layers were separated from the aqueous layers and evaporated. The residues were redissolved in 20 ml of hexane and analyzed by gas chromatography (Hewlett Packard 5890 series II) using a CPsil19 CB capillary column (24 mx0.25 mm, film thickness 0.2 mM, Chrompack, Middelburg, The Netherlands). Detection was performed by positive chemical ionization mass spectrometry (Hewlett Packard Engine 5989B) using methane as reactant gas. For pristanal-ethoxime, m/z 326 (M/1) was monitored, for dodecylaldehyde-ethoxime m/z 228 (M/1) was monitored.
Pristanic acid in the incubations was measured as its pentafluorobenzyl derivative by stable isotope dilution gas chromatography mass spectrometry with negative chemical ionization, essentially as described before for plasma samples [12] . Figure 1 shows the mass fragmentograms of a standard solution containing pristanal-ethoxime (RfÅ7.85 min.) and dodecylaldehyde-ethoxime (RfÅ5.62 min.). Pristanal-ethoxime gives a double peak in its mass fragmentogram, due to separation between its cis-and trans isomers. No separation between the stereoisomers of dodecylaldehyde-ethoxime is observed.
RESULTS
In incubations of homogenised human liver with 2hydroxyphytanoyl-CoA, formation of pristanal is observed, as is shown in fig. 1C . At tÅ0 ( fig. 1B) , no pristanal was detectable, whereas at tÅ100 min. (fig. 1C ) a significant amount of pristanal was formed. In these incubations, only a small amount of pristanic acid (0.4 nmol/ml) was formed.
In figure 2 the time dependence of the formation of pristanal in incubations of 2-hydroxyphytanoyl-CoA is shown. A linear increase in pristanal concentrations, as calculated by dividing the peak area of pristanalethoxime by the peak area of the internal standard dodecylaldehyde-ethoxime, was found during the first 60 minutes of incubation. Hereafter, no further increase occurred. In these incubations, to which no NAD / was added, only a small amount of pristanic acid (0.4 nmol/ml) was formed. When NAD / was added to the incubation medium, there was no detectable formation of pristanal as shown in fig.2 . Under these condi- dized to its corresponding fatty acid, in nature. Already in 1959 Martin and Stumpf described the a-oxidation of long chain fatty acids in peanuts [15] . A peroxidase enzyme shortens the chain of a fatty acid by one carbon atom, yielding a fatty aldehyde, which is further oxidised by a NAD / specific dehydrogenase giving the corresponding fatty acid. This process, however, was then found to be independent of activation of the fatty acids to their coenzyme A derivatives.
The data described in this paper suggest that the pathway of phytanic acid a-oxidation is finally resolved now. Following earlier findings that phytanic acid first undergoes activation to phytanoyl-CoA succeeded by hy- tions, however, there was a significant formation of pristanic acid (2.3 nmol/ml).
DISCUSSION
After long debates in literature about the mechanism of phytanic acid a-oxidation in man, the phytanic acid a-oxidation pathway has now been resolved. It is evident that the first step involves the activation of phytanic acid to phytanoyl-CoA, catalyzed by a peroxisomal acyl-CoA synthetase also accepting palmitic acid and pristanic acid as substrates [13] . The second step involves the hydroxylation of phytanoyl-CoA to 2-hydroxyphytanoyl-CoA via a dioxygenase type of enzyme localised in peroxisomes. In this paper we have studied the mechanism by which 2-hydroxyphytanoyl-CoA is further metabolised to pristanic acid. Our data show that the intermediate in this reaction is the fatty aldehyde pristanal ( fig. 3 ). The conversion of 2-hydroxyphytanoyl-CoA into pristanal is probably catalyzed by a lyase type of enzyme, similar to the breakdown of HMG-CoA to acetyl-CoA and acetoacetate by HMG-CoA lyase. The recent finding that formyl-CoA rather than formic acid is the other product of the decarboxylation process gives support to this idea [14] .
Pristanal is converted into pristanic acid in a NAD / dependent reaction, as was illustrated by the absence of pristanal and presence of pristanic acid in incubations to which NAD / was added. Oxidation of fatty aldehydes to their corresponding fatty acids has been described before [8] . Presumably, the formation of pris- 
